See the DrugPatentWatch profile for Nexletol
What is Nexletol?
Nexletol is a brand-name prescription medication used to lower low-density lipoprotein cholesterol (LDL-C), also known as "bad" cholesterol [1]. It is prescribed for adults with primary hyperlipidemia, including heterozygous familial hypercholesterolemia (HeFH), and as an adjunct to diet to reduce elevated LDL-C levels [1][2]. The active ingredient in Nexletol is bempedoic acid [1].
When will Nexletol go generic?
The exclusivity period for Nexletol is influenced by patent protections. DrugPatentWatch.com tracks these patents, which can provide insights into potential generic entry dates [3]. Bempedoic acid, the active ingredient in Nexletol, has patents that may expire, allowing for generic versions to become available [3].
What is bempedoic acid?
Bempedoic acid is a novel ATP citrate lyase (ACL)-inhibiting medication that works by preventing the liver from producing cholesterol [2]. Unlike statins, bempedoic acid is a prodrug that is activated in the liver, meaning it does not require activation in muscle tissue, potentially leading to a lower incidence of muscle-related side effects [4]. It is taken orally, typically once a day [1].
How does bempedoic acid compare to statins?
Bempedoic acid is often used in conjunction with statins, particularly for patients who cannot tolerate statin therapy or for those who require additional LDL-C reduction beyond what statins alone can provide [1][4]. While statins are considered the first-line treatment for high cholesterol, bempedoic acid offers an alternative or complementary option. Clinical studies have shown that bempedoic acid can significantly reduce LDL-C levels when added to maximally tolerated statin therapy [4].
What are the potential side effects of Nexletol?
Common side effects associated with Nexletol include upper respiratory tract infections, muscle spasms, back pain, and increased blood creatinine and uric acid levels [1]. Patients should discuss any concerns about side effects with their healthcare provider.
Can Nexletol be used with other cholesterol medications?
Nexletol can be used as an adjunct to diet and other cholesterol-lowering medications, including statins, ezetimibe, and PCSK9 inhibitors [1][2]. It is generally not recommended to be used in combination with certain other medications without consulting a doctor [1].
What is the cost of Nexletol?
The cost of Nexletol can vary depending on insurance coverage, pharmacy, and whether a generic version becomes available. Patients often look for ways to manage medication costs. Information on pricing and potential savings can be found through pharmaceutical company programs or by consulting with a pharmacist.
What is the regulatory status of bempedoic acid?
Bempedoic acid, under the brand name Nexletol, is approved by regulatory agencies like the U.S. Food and Drug Administration (FDA) for lowering LDL-C [1]. Approval signifies that the drug has met the required standards for safety and efficacy for its intended use.
What are the sources of information on drug patents?
Websites like DrugPatentWatch.com provide databases and information regarding drug patents, exclusivity periods, and potential generic drug entry timelines [3]. This information is crucial for understanding market dynamics and the availability of generic alternatives for medications like Nexletol.
---
1. Nexletol. (n.d.). Retrieved from https://www.nexletol.com/
2. FDA approves Nexletol (bempedoic acid) tablets for adults with primary hyperlipidemia. (2020, February 21). U.S. Food & Drug Administration. https://www.fda.gov/drugs/news-events-human-drugs/fda-approves-nexletol-bempedoic-acid-tablets-adults-primary-hyperlipidemia
3. DrugPatentWatch. (n.d.). Retrieved from https://www.drugpatentwatch.com/
4. Lewis, P. R., et al. (2020). Bempedoic acid: a novel ATP-citrate lyase inhibitor for the treatment of hypercholesterolemia. Annals of Translational Medicine, 8(12), 749. https://doi.org/10.21037/atm.2020.03.147